World Vaccine Market Will Be Worth $77.5 Billion by 2024
A new market study by Grand View Research, Inc. of San Francisco, CA estimates the value of the world vaccine market at $32.5 billion in 2015. The study forecasts the market to grow to $77.5 billion by 2024. Grand View Research attributes the growth mainly to the “rising demand for better healthcare infrastructure and high awareness levels of the…
Nordic Cochrane Center Files Complaint About Scientific Misconduct, Secrecy in HPV Vaccine Probe in Europe
Nordic Cochrane Center, a Danish research and information center is challenging the European Medicines Agency’s (EMA) 2015 report on human papillomavirus (HPV) vaccines and the EMA’s position that HPV vaccine benefits outweigh the risks. After numerous reports of HPV vaccine-related brain and immune system injuries and deaths…
Corporate Philanthropy & the Gates Foundation: Global Vaccine Program Conflicts of Interest
Bill Gates is reported to be one of the richest individuals on Earth, with a current net worth of $87.4 billion. The Bill & Melinda Gates Foundation (BMGF), founded in 2000, is the largest private foundation in the world. The foundation’s mission is to support and fund international development initiatives that improve social, economic and health conditions on a global level.
The Zika Breach of Public Trust: The Wealth Transfer Model From U.S. Taxpayers to Big Pharma
In less than a decade, the World Health Organization (WHO) has declared four global health emergencies, starting with the 2009 swine flu outbreak. In 2012, the “wild” polio outbreak followed the flu pandemic. Both fizzled out, underperforming their hyped lethal spread. At the Sixty-Fifth World Health Assembly “Poliomyelitis: intensification of the global eradication initiative,” which convened on April 5, 2012, the Secretariat Report stated: “In the majority of countries, out-of-season outbreaks are no longer being…
Gardasil 9 Vaccine Prompts Push for National Program
U.S. government health officials continue to push hard for a countrywide mandate of human papillomavirus (HPV) vaccination. They maintain that the cost-benefit ratio of the new nonavalent Gardasil vaccine, which contains nine HPV strains, the ticket to succeeding in their efforts to get every girl and boy in America to take the vaccine. In 2006, a 4-strain version of Merck’s Gardasil vaccine was the first HPV vaccine to be fast tracked to licensure in the U.S. and it contained two HPV strains associated with cervical…
Study: World Vaccine Market Will Be Worth $45.1 Billion by 2022
A new market study by Kalorama Information, LLC of Rockville, MD estimates the value of the world vaccine market at $27.6 billion in 2015—up 11% from $24.7 billion in 2014 and 14% from $23.6 billion in 2013, reports Genetic Engineering Biotechnology News (GEN). According to the study, the market is projected to grow to $45.1 billion by 2022, owing to the continued…